Vaginal Dilation Doesn't Prevent Radiotherapy Damage | Radiology
LinkedIn Login

Connect healthcare products, companies and hospitals with your LinkedIn network.

Facebook Login

Interact with your Facebook network around healthcare products, companies and hospitals.

Login With Facebook
MedicExchange Login

Enjoy Premium Access as a MedicExchange Member.

       Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Facebook Twitter Linkedin
Facebook: MedicExchange
Twitter: MedicExchange

Gold Standard

Radiology Vaginal Dilation Doesn't Prevent Radiotherapy Damage

Vaginal Dilation Doesn't Prevent Radiotherapy Damage

Radiology News - Radiology

radiologyWhile vaginal dilation might help treat late effects of pelvic irradiation, evidence does not support routine dilation during or immediately after radiotherapy.

This finding from a meta-analysis is in contrast to current UK guidelines, which recommend routine vaginal dilation during and after pelvic radiotherapy to prevent stenosis.

In their report, lead author Dr. Nicholas Johnson of Royal United Hospital, Bath, U.K., and colleagues note that vaginal dilation has been associated with traumatic rectovaginal fistulae and "psychological consequences." If dilation during or after radiotherapy is to be recommended, "we must acknowledge its rare potential for serious harm and accept the cost of supporting women during therapy, and we must be sure we understand the rationale for treatment," they write.

The researchers performed a Cochrane-style systematic review and meta-analysis to assess data relevant to vaginal dilation and stenosis associated with pelvic radiotherapy for endometrial and cervical cancer. Their results were published February 16th online in BJOG.

Out of 256 studies that commented on vaginal dilation, "very few contained data from any...scientific study," the authors say.

A number of trials gave recommendations on dilation therapy, but only seven focused on stenosis associated with radiotherapy. Vaginal fistulas or psychological morbidity are described in case reports. Two studies reported that encouraging dilation increased compliance; however, there was no difference in sexual function scores.

One study revealed no advantage from inserting mitomycin C. One report that included five cases implied that stenosis can be treated by dilation many years after radiotherapy. Another report implied that stenosis rates were lowered with dilation, but the control group was not comparable.

In one uncontrolled study with 89 women, the median vaginal length 6 to 10 weeks after therapy was 6 cm. Four months later, the median length was 9 cm. No further significant increase was achieved with continued dilation 4 and 8 months later.

"The psychological implications of imposing (dilation) therapy are very variable, and can't be assessed by a formal quantitative study," the authors write, nor can the "physical trauma associated with (dilation) during the healing peri-inflammatory phase."

They conclude that current UK guidelines should be revisited because vaginal dilation during radiotherapy is: "(i) costly in terms of healthcare time; (ii) plausibly associated with greater scar formation, rather than less; (iii) associated with case reports of very serious damage following its treatment; (iv) causes psychological sequelae for some women; and (v) there is no good supporting evidence for it."
 
Source: ACR

Discuss more about Radiology in the Radiology user group.

 

Related Articles